Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

NCT01138202 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
Tuberculosis

Interventions

DRUG: LPV/r

Sponsor

The HIV Netherlands Australia Thailand Research Collaboration

Collaborators

[object Object]